Literature DB >> 32153662

10-Hydroxy-2-Decenoic Acid Prevents Ultraviolet A-Induced Expression of Lamin AÄ150 in Human Dermal Fibroblasts.

Shahrzad Mirbaha1, Morteza Bagheri1, Salar Mahmoudi-Nejad1.   

Abstract

10-Hydroxy-2-decenoic acid (10-HDA) as the main component of royal jelly has pharmacological characteristics. But the influence of 10-HDA on skin photoaging and photo damage is poorly understood. In the present study, we used 10-HAD immediately after UVA exposure and tested the effects on the attenuation of LMNAÄ150 expression in cultured human dermal fibroblasts Human dermal fibroblasts (cultured cells) were exposed to UVA irradiation. The mRNA level of LMNAÄ150 was determined by Taqman Real-Time PCR Assay. Real-time PCR analysis of LMNAÄ150 transcripts indicated that the level of LMNAÄ150 transcripts was higher in the UVA exposed group than the group treated with 10-HAD after UVA exposure (>8.22-fold). The LMNAÄ150 expression is down-regulated in human dermal fibroblasts after treatment with 10-HDA. It can be concluded that treatment with 10-HDA suppresses the UVA-induced gene expression of LMNAÄ150 and protects skin from UVA-induced photoaging and photo damage.

Entities:  

Year:  2019        PMID: 32153662      PMCID: PMC7035451          DOI: 10.26574/maedica.2019.14.4.327

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  29 in total

1.  [UV-radiation--sources, wavelength, environment].

Authors:  Erhard Hölzle; Herbert Hönigsmann
Journal:  J Dtsch Dermatol Ges       Date:  2005-09       Impact factor: 5.584

2.  Molecular basis of sun-induced premature skin ageing and retinoid antagonism.

Authors:  G J Fisher; S C Datta; H S Talwar; Z Q Wang; J Varani; S Kang; J J Voorhees
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

3.  Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice.

Authors:  Loren G Fong; Jennifer K Ng; Margarita Meta; Nathan Coté; Shao H Yang; Colin L Stewart; Terry Sullivan; Andrew Burghardt; Sharmila Majumdar; Karen Reue; Martin O Bergo; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

Review 4.  Melanoma and sun exposure: an overview of published studies.

Authors:  J M Elwood; J Jopson
Journal:  Int J Cancer       Date:  1997-10-09       Impact factor: 7.396

5.  Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients.

Authors:  Gabriela Viteri; Youn Wook Chung; Earl R Stadtman
Journal:  Mech Ageing Dev       Date:  2009-12-01       Impact factor: 5.432

Review 6.  Aging and nuclear organization: lamins and progeria.

Authors:  Leslie C Mounkes; Colin L Stewart
Journal:  Curr Opin Cell Biol       Date:  2004-06       Impact factor: 8.382

7.  Compositions of royal jelly II. Organic acid glycosides and sterols of the royal jelly of honeybees (Apis mellifera).

Authors:  Tetsuya Kodai; Kazue Umebayashi; Takafumi Nakatani; Kaori Ishiyama; Naoki Noda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-10       Impact factor: 1.645

8.  Longwave UV light induces the aging-associated progerin.

Authors:  Hirotaka Takeuchi; Thomas M Rünger
Journal:  J Invest Dermatol       Date:  2013-02-07       Impact factor: 8.551

9.  Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides.

Authors:  Loren G Fong; Timothy A Vickers; Emily A Farber; Christine Choi; Ui Jeong Yun; Yan Hu; Shao H Yang; Catherine Coffinier; Roger Lee; Liya Yin; Brandon S J Davies; Douglas A Andres; H Peter Spielmann; C Frank Bennett; Stephen G Young
Journal:  Hum Mol Genet       Date:  2009-04-17       Impact factor: 6.150

10.  10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells.

Authors:  Hiroshi Izuta; Yuichi Chikaraishi; Masamitsu Shimazawa; Satoshi Mishima; Hideaki Hara
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.